A Rughetti1, V Turchi, C A Ghetti
1Department of Experimental Medicine, University of Rome, Italy.
Researchers identified a human antibody (BB5) that targets polymorphic epithelial mucin (PEM) on ovarian cancer cells. This discovery supports using synthetic PEM peptides as a potential cancer vaccine, alongside existing T-cell therapies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: